Literature DB >> 3105472

Nebulised sodium cromoglycate and verapamil in methacholine induced asthma.

A L Boner, G Vallone, A Andreoli, R Biancotto, J O Warner.   

Abstract

Fifteen children with asthma underwent challenges with methacholine on separate days after double blind administration by nebuliser of either verapamil (5 mg), cromoglycate (20 mg), or saline (placebo). The provocation doses that produced a 20% fall in forced expiratory volume in one second (PD20) were analysed. There was variation in the protective effects of verapamil and cromoglycate among the patients. Although cromoglycate produced an increase in PD20 in 53% of the children tested, the protection was not significant when compared with the placebo. Verapamil was partially protective, however, in 80% of children and achieved significantly better results than the placebo. We suggest that this is likely to be due to a direct effect on bronchial smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3105472      PMCID: PMC1778310          DOI: 10.1136/adc.62.3.264

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  16 in total

1.  Protective effect of drugs on histamine-induced asthma.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Thorax       Date:  1977-08       Impact factor: 9.139

2.  The emerging role of bronchoprovocation.

Authors:  R R Rosenthal
Journal:  J Allergy Clin Immunol       Date:  1979-12       Impact factor: 10.793

3.  Effect of cromolyn on carbachol-induced bronchoconstriction.

Authors:  L M Fabbri; C E Mapp; D J Hendrick
Journal:  Ann Allergy       Date:  1983-03

4.  Calcium channel antagonists in coronary artery spasm and bronchial spasm. What do variant angina and bronchial asthma have in common?

Authors:  R G Townley
Journal:  Chest       Date:  1982-10       Impact factor: 9.410

5.  Altitude and house dust mites.

Authors:  D Vervloet; A Penaud; H Razzouk; M Senft; A Arnaud; C Boutin; J Charpin
Journal:  J Allergy Clin Immunol       Date:  1982-03       Impact factor: 10.793

Review 6.  Bronchial hyperreactivity.

Authors:  H A Boushey; M J Holtzman; J R Sheller; J A Nadel
Journal:  Am Rev Respir Dis       Date:  1980-02

7.  Reproducibility and comparison of responses to inhaled histamine and methacholine.

Authors:  E F Juniper; P A Frith; C Dunnett; D W Cockcroft; F E Hargreave
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

8.  Sodium cromoglycate-induced changes in the dose-response curve of inhaled methacholine and histamine in asthmatic children.

Authors:  R Woenne; M Kattan; H Levison
Journal:  Am Rev Respir Dis       Date:  1979-06

9.  Cromolyn therapy in patients with bronchial asthma. Effect on inhalation challenge with allergen, histamine, and methacholine.

Authors:  U Y Ryo; B Kang; R G Townley
Journal:  JAMA       Date:  1976-08-23       Impact factor: 56.272

10.  The effect of verapamil on histamine and methacholine-induced bronchoconstriction.

Authors:  K R Patel
Journal:  Clin Allergy       Date:  1981-09
View more
  2 in total

Review 1.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

2.  Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment.

Authors:  John D Brannan; M Diane Lougheed
Journal:  Front Physiol       Date:  2012-12-10       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.